Search
forResearch 10 of 1000+
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- Ethinylestradiol/Chlormadinone Acetate
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Ethinylestradiol/Chlormadinone Acetate
- Foreword
- Progress on clinical applications of chlormadinone acetate
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Hormonal contraceptives: pharmacology tailored to women's health
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →